166 related articles for article (PubMed ID: 9233905)
1. Kinins are implicated of the hypotensive effect of acidic fibroblast growth factor.
Saenz de Tejada I; Carceller F; Fernandez A; Cuevas B; Ortes L; Giménez-Gallego G; Cuevas P
Eur J Med Res; 1997 Jul; 2(7):302-4. PubMed ID: 9233905
[TBL] [Abstract][Full Text] [Related]
2. Adrenomedullary catecholamine, pressor and chronotropic responses to human coagulation beta-FXIIa mediated by endogenous kinins.
Amfilochiadis AA; Backx PH; Floras JS
J Hypertens; 2008 Jan; 26(1):61-9. PubMed ID: 18090541
[TBL] [Abstract][Full Text] [Related]
3. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
[TBL] [Abstract][Full Text] [Related]
4. Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kininogen-deficient rats.
Liu YH; Yang XP; Mehta D; Bulagannawar M; Scicli GM; Carretero OA
Am J Physiol Heart Circ Physiol; 2000 Feb; 278(2):H507-14. PubMed ID: 10666082
[TBL] [Abstract][Full Text] [Related]
5. Kinin antagonist does not protect against the hypotensive response to endotoxin, anaphylaxis or acute pancreatitis.
Berg T; Schlichting E; Ishida H; Carretero OA
J Pharmacol Exp Ther; 1989 Nov; 251(2):731-4. PubMed ID: 2810121
[TBL] [Abstract][Full Text] [Related]
6. Effects of a neutral endopeptidase inhibitor, BP102, on the development of deoxycorticosterone acetate-salt hypertension in kininogen-deficient Brown Norway Katholiek rats.
Nakajima S; Majima M; Ito H; Hayashi I; Yajima Y; Katori M
Int J Tissue React; 1998; 20(2):45-56. PubMed ID: 9638501
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of endotoxin-induced hypotension in kininogen-deficient rats with that in normal rats.
Ueno A; Ishida H; Oh-ishi S
Br J Pharmacol; 1995 Mar; 114(6):1250-6. PubMed ID: 7620716
[TBL] [Abstract][Full Text] [Related]
8. Role of angiotensin II type 2 receptors and kinins in the cardioprotective effect of angiotensin II type 1 receptor antagonists in rats with heart failure.
Liu YH; Yang XP; Shesely EG; Sankey SS; Carretero OA
J Am Coll Cardiol; 2004 Apr; 43(8):1473-80. PubMed ID: 15093886
[TBL] [Abstract][Full Text] [Related]
9. Involvement of kinins in hyperresponsiveness induced by platelet activating factor in the human nasal airway.
Turner PJ; Dear JW; Foreman JC
Br J Pharmacol; 2000 Feb; 129(3):525-32. PubMed ID: 10711351
[TBL] [Abstract][Full Text] [Related]
10. Kinins mediate the inhibition of atrial natriuretic peptide diuretic effect induced by pepsanurin.
Boric MP; Croxatto HR; Moreno JM; Silva R; Hernandez C; Roblero JS
Biol Res; 1998; 31(1):33-48. PubMed ID: 10347745
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
Vianna RM; Calixto JB
Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
[TBL] [Abstract][Full Text] [Related]
12. Role of kinins in the cardioprotective effect of preconditioning: study of myocardial ischemia/reperfusion injury in B2 kinin receptor knockout mice and kininogen-deficient rats.
Yang XP; Liu YH; Scicli GM; Webb CR; Carretero OA
Hypertension; 1997 Sep; 30(3 Pt 2):735-40. PubMed ID: 9323015
[TBL] [Abstract][Full Text] [Related]
13. In vivo evidence for B1-receptor synthesis induction by heat stress in the rat.
Lagneux C; Ribuot C
Br J Pharmacol; 1997 Jul; 121(6):1045-6. PubMed ID: 9249236
[TBL] [Abstract][Full Text] [Related]
14. Does insulin release kinins in rats?
Damas J; Garbacki N; Lefèbvre PJ
Eur J Pharmacol; 2005 Nov; 525(1-3):154-60. PubMed ID: 16297383
[TBL] [Abstract][Full Text] [Related]
15. EDHF-mediated rapid restoration of hypotensive response to acetylcholine after chronic, but not acute, nitric oxide synthase inhibition in rats.
Desai KM; Gopalakrishnan V; Hiebert LM; McNeill JR; Wilson TW
Eur J Pharmacol; 2006 Sep; 546(1-3):120-6. PubMed ID: 16876156
[TBL] [Abstract][Full Text] [Related]
16. Bradykinin inhibits development of myocardial infarction through B2 receptor signalling by increment of regional blood flow around the ischaemic lesions in rats.
Ito H; Hayashi I; Izumi T; Majima M
Br J Pharmacol; 2003 Jan; 138(1):225-33. PubMed ID: 12522094
[TBL] [Abstract][Full Text] [Related]
17. Signalling pathways in bradykinin- and nitric oxide-induced hypotension in the normotensive rat; role of K+-channels.
Berg T; Koteng O
Br J Pharmacol; 1997 Jul; 121(6):1113-20. PubMed ID: 9249246
[TBL] [Abstract][Full Text] [Related]
18. High sensitivity to salt in kininogen-deficient brown Norway Katholiek rats.
Majima M; Yoshida O; Mihara H; Muto T; Mizogami S; Kuribayashi Y; Katori M; Oh-ishi S
Hypertension; 1993 Nov; 22(5):705-14. PubMed ID: 7693588
[TBL] [Abstract][Full Text] [Related]
19. A study of the mediators involved in the protection induced by exogenous kinins in the isolated rat heart.
Lagneux C; Adam A; Lamontagne D
Int Immunopharmacol; 2003 Oct; 3(10-11):1511-8. PubMed ID: 12946448
[TBL] [Abstract][Full Text] [Related]
20. Blockade of bradykinin B(2) receptor suppresses acute pancreatitis induced by obstruction of the pancreaticobiliary duct in rats.
Hirata M; Hayashi I; Yoshimura K; Ishii K; Soma K; Ohwada T; Kakita A; Majima M
Br J Pharmacol; 2002 Jan; 135(1):29-36. PubMed ID: 11786477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]